SCHEMBL7528362

SCHEMBL7528362

COc1ccc(C(=O)Nc2ccn(CC(=O)O)c(=O)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 4/20 0.51
F2 P00734 1/20 0.50
DEGS1 O15121 2/20 0.49
NPC1 O15118 6/20 0.47
RAB9A P51151 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
TP53 P04637 3/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
ALOX15 P16050 1/20 0.46
MAPT P10636 2/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
KDM4E B2RXH2 1/20 0.45
RECQL P46063 1/20 0.45
RXFP1 Q9HBX9 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263673 0.85 FPR2 (0.47) ADORA3F2DEGS1NPC1RAB9A
SCHEMBL452423 0.85 KMT2A (0.54) ADORA3NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7635962 0.84 DEGS1 (0.48) DEGS1NPC1RAB9ASMN1; SMN2TP53
SCHEMBL3136443 0.82 ABL1 (0.53) NPC1RAB9AMAPTALDH1A1
SCHEMBL6046930 0.78 MAPT (0.42) ADORA3F2DEGS1NPC1RAB9A
SCHEMBL454099 0.75 MAPT (0.50) F2NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL22672647 0.75 MEN1 (0.54) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL8299962 0.74 MEN1 (0.45) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL27041152 0.74 ADORA3 (0.45) ADORA3F2NPC1RAB9ARXFP1
SCHEMBL27041189 0.74 ADORA3 (0.45) ADORA3F2NPC1RAB9ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6465650-B1 INTERMEDIATE STEPS IN PREPARING PEPTIDE NUCLEIC ACIDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-10-15 US disclosed
EP-0761681-B1 Process for the preparation of substituted derivatives of N-ethylglycine HOECHST AG (DE) 2002-03-13 EP disclosed
EP-0761681-A2 Process for the preparation of substituted derivatives of N-ethylglycine HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-12 EP disclosed